EU Marie Curie Actions:

approach for excellent doctoral training

CEICS Forum 2011, Tarragona, 9 November 2011

Vanessa Debiais-SaintonPolicy OfficerDG Education, Culture, Multilingualism and YouthUnit C3, Marie Curie Actions

“By bridging education and research, and reaching out to industry,

Marie Curie Actions are a strong enabler for at least three of these flagships

– the Innovation Union, Youth on the Move and

the Agenda for new skills and jobs.”President Barroso, 10 December 2010

EUROPE 2020 & 7 flagship initiatives:SMART, SUSTAINABLE and INCLUSIVE GROWTH

Yout

h O

n th

e M

ove • Promote

researchers mobility across sectors, countries and disciplines

• Attractiveness of European universities

• Stronger links between education, research and innovation

Inno

vatio

n Un

ion • 1 million more

researchers• Attract and

train young people to become researchers

• Improve quality of doctoral training

• Involve businesses in doctoral training Th

e A

gend

a fo

r New

Ski

lls a

nd J

obs • Equip

researchers with relevant skills that will match both public and private sector needs

• Improve career prospects of doctoral candidates

Inter-disciplinary

Multi-ITNs

Mono-ITNs

2011

2 Implementation Modes

2012

3 Implementation Modes

Multi-ITNs

InnovativeDoctoral

Programmes

~400 M€

20 M€

≥3

1

EuropeanIndustrial

Doctorates

2

Food

Pharma

Electronics

Hospital

Multi-ITNs

• At least 3 participants from 3 different MS/AC+ associated partners,

• Network of participants from different countries, sectors and disciplines

• Short-term secondments of ESRs

• Networking activities

• Equip ESRs with innovative skills (scientific and transversal skills)

Universityor Industry

Country 1

Country 2Country 3

"The Marie Curie ITN scheme in FP7 has opened a way to train the next generation of scientists in understanding both the academic and business cultures. It can act as a model for universities to develop similar activities” (EARMA)

Food

Pharma

Electronics

Hospital

• 1 participant (MS/AC)

• Associated partners from any country, sector and discipline

• Innovative training programme: intersectoral, international, interdisciplinary

• Equip doctoral candidates with innovative skills (scientific and transversal skills)

• Quality and quantity of supervision of doctoral candidates

Innovative Doctoral ProgrammesCountry 1

Universityor Industry

Industry

Other country

Other discipline

Other sector

Universityor Industry

“Marie Curie Actions should be extended to include the funding of structured education and training through doctoral programmes and doctoral schools” (IE National Position)

institution

University or

Research institution

Food

Pharma

Electronics

Hospital

• e.g. Intersectoral dimension can be addressed by:

Inviting researchers working in industry or other socio-economic actors to deliver courses on entrepreneurship, exploitation of research results, ethics, patenting, etc;

Mentoring of doctoral candidates by researchers and/or experts from industry or from other socio-economic actors;

Exposing researchers to various socio-economic actors gathered in a single campus or hub;

Offering placement opportunities for several weeks or months to young researchers to develop their research projects at the premises of future employers.

Innovative Doctoral Programmes

Food

Pharma

Electronics

Hospital

e.g. International dimension can be addressed by:

Offering possibilities to take courses abroad;

Developing partnerships and/or joint degrees with other research institutions or companies in different countries;

e.g. Interdisciplinary dimension can be addressed by:

Proposing common courses or projects to doctoral candidates from different disciplines;

Bringing together doctoral candidates in multi-disciplinary projects involving different research teams from the same or different institutions;

Offering possibilities of laboratory rotations or visits.

Innovative Doctoral Programmes

Pharma

Electronics

Hospital

European Industrial Doctorates

A.Vassiliou, 10 December 2010:

“I believe we need to launch, within Marie Curie, a European Industrial doctorate

Scheme. Indeed, University-led research and innovation has marked up huge

successes in many parts of the Union. But partnerships with business are more

than markets for new ideas. They help researchers develop the business flair that

turns research into a commercial proposition. And they make the walls between

education and business more permeable: if people can forge careers that move in

and out of the two worlds, knowledge and know-how really will transfer across.”

Pharma

Electronics

Hospital

• 2 participants: 1 academic, 1 private sector (MS/AC only)

• Possible associated partners from any country and any sector

• Each researcher must:be enrolled in a doctoral programmebe employed by at least one of the participantsspend at least 50% of the time in private sectorbe jointly supervised by both participants

• 1 to 5 researchers / project & consortium agreement mandatory

≥ 50%

Industry

Country 1 Country 2

European Industrial Doctorates

Pharma

Electronics

Hospital

• Involve companies in doctoral training

• Develop innovative aptitudes and entrepreneurial mindsets

• Improve the employability and career perspectives of doctorate holders

• Strengthen the cooperation between universities and companies

• Enhance the research potential and competitiveness of European companies and SMEs

≥ 50%

Industry

Country 1 Country 2

“In the EID, researchers can acquire an excellent level of training and recognised research experience, learn how to deal with the real-life situations the company faces and learn how to evolve instinctively within these two distinct worlds ” (Business Europe)

European Industrial Doctorates

Pharma

Electronics

Hospital

Multi-ITN IDP EID

Partners level-13 minimum

3 diff. MS/AC1

any MS/AC2

2 diff. MS/AC

Partners level-2 unlimited(any country/sector/disc.)

unlimited(any country/sector/disc.)

unlimited(any country/sector/disc.)

Private sector involvement

highest possible level (partners level 1 and 2)

expected via associated partners

1 partner level 1 + associated partners

Eligible researchers

ESR (3-36 months)ER (3-24 months) = 20%

ESR (3-36 months) ESR (3-36 months)

PhD enrolment typically expected (ESR) mandatory mandatory

Intersectoral aspects

secondments encouraged (= 30%)

secondments encouraged (= 30%)

= 50% in private sector

Res. months 500 max 500 max 180 max

Budget/country 40% max to 1 country n/a n/a

Panels and ranking lists

8 ranking lists (corresponding to scientific panels CHE, ECO, ENG, ENV, LIF, MAT, PHY, SOC)

EID ranking list (20M€ earmarked)

Multi-ITN IDP EID

Partners level-13 minimum

3 diff. MS/AC1

any MS/AC2

2 diff. MS/AC

Partners level-2 unlimited(any country/sector/disc.)

unlimited(any country/sector/disc.)

unlimited(any country/sector/disc.)

Private sector involvement

highest possible level (partners level 1 and 2)

expected via associated partners

1 partner level 1 + associated partners

Eligible researchers

ESR (3-36 months)ER (3-24 months) = 20%

ESR (3-36 months) ESR (3-36 months)

PhD enrolment typically expected (ESR) mandatory mandatory

Intersectoral aspects

secondments encouraged (= 30%)

secondments encouraged (= 30%)

= 50% in private sector

Res. months 500 max 500 max 180 max

Budget/country 40% max to 1 country n/a n/a

Panels and ranking lists

8 ranking lists (corresponding to scientific panels CHE, ECO, ENG, ENV, LIF, MAT, PHY, SOC)

EID ranking list (20M€ earmarked)

Pharma

Electronics

Hospital

Category 1: Monthly Living Allowance- €38,000 gross salary per ESR / year x country coefficient- €58,500 gross salary per ER / year x country coefficient (Multi-ITN)

Category 2: Mobility Allowance- €1,000 – €700 (family or not) per researcher month x country coefficient- Flat-rate cost category

Category 3: Contribution to Training & Research Costs- €1,800 per researcher month (Multi-ITN)- €1,200 per researcher month (EID and IDP)- Flat-rate cost category

Category 4: Management Activities- Maximum 10% of total EU contribution (i.e. 10% of C1+C2+C3+C4+C5)- Real costs category

Category 5: Overheads- 10% of direct costs (i.e. 10% of C1+C2+C3+C4)- Flat-rate cost category

Pharma

Electronics

Hospital

Budget 423.23 M€including 20 M€ for EID

Timetable

Publication 20 July 2011Closure 12 Jan 2012 (17:00 Brussels time)Remote evaluation 20 Feb – 11 March 2012Central evaluation 26–30 March 2012Info to applicants May 2012Launch of nego. June 2012First GA signed September 2012

Pharma

Electronics

Hospital

Call published on the Research Participant Portalhttp://ec.europa.eu/research/participants/portal/

• Publication of FP7 calls officially switched from CORDIS to the Research Participant Portal.

• FP7 calls no longer published on CORDIS. CORDIS users redirected to the relevant Participant Portal pages.

We need a meeting of minds,

between business, academia and public authorities,

to ensure our researchers are equipped

with the best cutting-edge skills.President Barroso, 10 December 2010

THANK YOU

FOR YOUR

ATTENTION

http://ec.europa.eu/mariecurieactions